Ketoprofen lysine salt for relieving acute pain: a multi-regression analysis

Published on March 15, 2026

Panminerva Med. 2026 Mar;68(1):41-45. doi: 10.23736/S0031-0808.25.05421-7.

ABSTRACT

INTRODUCTION: Acute pain is a common symptom that requires prompt and adequate treatment. Ketoprofen lysine salt (KLS) is a non-steroidal anti-inflammatory drug (NSAID) able to rapidly relieves mild-moderate acute pain in children and adolescents. The present study aimed to perform a meta-analysis of controlled studies on this issue.

EVIDENCE ACQUISITION: A scientific literature search selected three controlled trials concerning the KLS use in patients with acute pain. A meta-regression analysis was performed.

EVIDENCE SYNTHESIS: The overall trend, modeled through weighted linear regression, confirms a significant time-dependent reduction in pain scores by KLS. The onset of action is quick and analgesic effect is prolonged.

CONCLUSIONS: This meta-regression analysis showed that KLS could relieve mild to moderate acute pain promptly and in a prolonged manner over time, as desired by a patient with acute pain.

PMID:41814920 | DOI:10.23736/S0031-0808.25.05421-7

Continue reading on website
Other news

The Topographical, Sensory, and Temporal Characteristics of Pain in Parkinson's Disease: A Cross-Sectional Survey

March 15, 2026
Pain Pract. 2026 Apr;26(4):e70142. doi: 10.1111/papr.70142.ABSTRACTBACKGROUND: Pain in Parkinson's disease (PD) manifests clinically in a variety of ways and several pain types have been identified, however, their characteristics have not been extensively studied.OBJECTIVE: To describe the characteristics of common pain types in people with PD.METHODS: A survey of people with PD that experience pa

Case Report: Spinal cord stimulation for neuropathic pain from spinal cysticercosis

March 15, 2026
Front Neurosci. 2026 Feb 24;20:1742006. doi: 10.3389/fnins.2026.1742006. eCollection 2026.ABSTRACTRATIONALE: Spinal cord cysticercosis, an exceptionally rare form of neurocysticercosis (NCC), often leads to refractory neuropathic pain and neurological deficits. Current treatments (e.g., antiparasitics or decompressive surgery) may fail to alleviate symptoms, necessitating alternative strategies. S